Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC Meeting Abstract


Authors: Wong, D. J. L.; Schneider, J. G.; Aljumaily, R.; Korn, W. M.; Infante, J. R.; Patel, M. R.; Autio, K. A.; Papadopoulos, K. P.; Naing, A.; Gabrail, N. Y.; Munster, P. N.; Goldman, J. W.; Van Vlasselaer, P.; Brown, G. L.; Hung, A.; Oft, M.; Garon, E. B.
Abstract Title: Efficacy, safety, and immune activation with pegylated human IL-10 (AM0010) in combination with an anti-PD1 in advanced NSCLC
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 471s
Language: English
ACCESSION: WOS:000411932202150
DOI: 10.1200/JCO.2017.35.15_suppl.9091
PROVIDER: wos
Notes: Meeting Abstract: 9091 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Karen Anne Autio
    119 Autio